HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoon Sin Oh Selected Research

YH-GKA

1/2014Treatment with glucokinase activator, YH-GKA, increases cell proliferation and decreases glucotoxic apoptosis in INS-1 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoon Sin Oh Research Topics

Disease

7Neoplasms (Cancer)
05/2022 - 01/2016
7Insulin Resistance
06/2021 - 10/2006
7Type 2 Diabetes Mellitus (MODY)
01/2020 - 10/2006
4Inflammation (Inflammations)
05/2022 - 02/2016
4Hyperglycemia
05/2020 - 01/2011
4Diabetic Nephropathies (Diabetic Nephropathy)
06/2019 - 01/2017
3Fibrosis (Cirrhosis)
05/2022 - 08/2017
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2018
2Body Weight (Weight, Body)
05/2020 - 02/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2022
1Liver Diseases (Liver Disease)
05/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
05/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Hyperplasia
06/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Stomach Neoplasms (Stomach Cancer)
01/2019
1Insulinoma
05/2018
1Multiple Sclerosis
01/2018
1Myocardial Infarction
01/2018
1Chronic Disease (Chronic Diseases)
12/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2017
1Diabetes Complications
07/2016
1Diabetic Neuropathies (Diabetic Neuropathy)
07/2016
1Hyperlipidemias (Hyperlipidemia)
07/2016
1Non-alcoholic Fatty Liver Disease
02/2016
1Prostatic Neoplasms (Prostate Cancer)
01/2016
1Adenocarcinoma
01/2016
1Mitochondrial Diseases (Mitochondrial Disease)
01/2013

Drug/Important Bio-Agent (IBA)

7Glucose (Dextrose)FDA LinkGeneric
05/2020 - 10/2006
4PF-543IBA
05/2022 - 01/2018
4sphingosine kinaseIBA
05/2022 - 05/2020
4Insulin (Novolin)FDA Link
06/2021 - 01/2011
4Caveolin 1IBA
11/2019 - 10/2006
3LipidsIBA
01/2022 - 02/2016
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022 - 12/2019
2Blood Glucose (Blood Sugar)IBA
05/2020 - 02/2016
2CytokinesIBA
01/2020 - 06/2019
2lysophosphatidic acidIBA
06/2019 - 01/2019
1TriazolesIBA
05/2022
1Transforming Growth Factor beta (TGF-beta)IBA
05/2022
1InflammasomesIBA
05/2022
1sulfurylase kinaseIBA
01/2022
1GTP-Binding Proteins (G-Protein)IBA
01/2022
1SphingosineIBA
01/2022
1Phosphates (Orthophosphate)IBA
01/2022
1SphingolipidsIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1CeramidesIBA
01/2022
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2022
1Small Interfering RNA (siRNA)IBA
01/2022
1Protein Isoforms (Isoforms)IBA
01/2022
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
06/2021
1Tight Junction ProteinsIBA
10/2020
1AntibodiesIBA
01/2020
1Infliximab (Remicade)FDA Link
01/2020
1Adalimumab (Humira)FDA Link
01/2020
1canakinumabFDA Link
01/2020
1Proteins (Proteins, Gene)FDA Link
11/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2019
1Annexin A5IBA
05/2018
1PalmitatesIBA
05/2018
1Caspase 3 (Caspase-3)IBA
05/2018
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2018
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
12/2017
1Free RadicalsIBA
12/2017
1Glucagon-Like Peptide 1 (GLP 1)IBA
12/2017
1angelicinIBA
08/2017
1CollagenIBA
08/2017
1Fibronectins (Fibronectin)IBA
08/2017
1Ficusin (Psoralen)IBA
08/2017
1Messenger RNA (mRNA)IBA
08/2017
1Streptozocin (Streptozotocin)FDA Link
08/2017
1Plasminogen Activator Inhibitor 1IBA
08/2017
1Lysophosphatidic Acid ReceptorsIBA
01/2017
1Neuroprotective AgentsIBA
07/2016
1benzyl isothiocyanateIBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1glucotropeolinIBA
01/2016
1BetacellulinIBA
11/2015
1YH-GKAIBA
01/2014
1bakuchiolIBA
01/2013
1Interleukin-6 (Interleukin 6)IBA
11/2011
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2011
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
06/2007

Therapy/Procedure

3Therapeutics
05/2022 - 01/2014
1Activities of Daily Living (ADL)
06/2021
1Intraperitoneal Injections
05/2020
1Oral Administration
05/2020
1Orchiectomy (Orchidectomy)
01/2011